# NanoSpectrometer Biomarker Discovery and Confirmation Study

> **NCT03275688** · — · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 332 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Breath Analysis

## Key facts

- **NCT ID:** NCT03275688
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-05
- **Primary completion:** 2020-07-06
- **Final completion:** 2020-07-06
- **Target enrollment:** 332 (ACTUAL)
- **Why stopped:** Interim analysis showed sample size sufficient for final analysis
- **Last updated:** 2020-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03275688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03275688, "NanoSpectrometer Biomarker Discovery and Confirmation Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03275688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
